Dashboard
Manage Tickers

DMAC DiaMedica Therapeutics Inc.

Nasdaq diamedica.com


$ 7.06 $ 0.42 (6.33 %)    

Monday, 13-Oct-2025 15:59:57 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 595.97 $ 0.00 (0 %)
DIA $ 458.58 $ 0.00 (0 %)
SPY $ 658.03 $ 0.00 (0 %)
TLT $ 91.14 $ 0.00 (0 %)
GLD $ 380.83 $ 0.00 (0 %)
$ 7.06
$ 6.65
$ 6.51 x 1
$ 7.20 x 19
-- - --
$ 3.19 - $ 7.49
410,930
na
364.92M
$ 0.91
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-12-2025 06-30-2025 10-Q
2 05-13-2025 03-31-2025 10-Q
3 03-17-2025 12-31-2024 10-K
4 11-13-2024 09-30-2024 10-Q
5 08-07-2024 06-30-2024 10-Q
6 05-08-2024 03-31-2024 10-Q
7 03-19-2024 12-31-2023 10-K
8 11-13-2023 09-30-2023 10-Q
9 08-14-2023 06-30-2023 10-Q
10 05-15-2023 03-31-2023 10-Q
11 03-28-2023 12-31-2022 10-K
12 11-09-2022 09-30-2022 10-Q
13 08-10-2022 06-30-2022 10-Q
14 05-04-2022 03-31-2022 10-Q
15 03-14-2022 12-31-2021 10-K
16 11-10-2021 09-30-2021 10-Q
17 08-11-2021 06-30-2021 10-Q
18 05-05-2021 03-31-2021 10-Q
19 03-10-2021 12-31-2020 10-K
20 11-04-2020 09-30-2020 10-Q
21 08-11-2020 06-30-2020 10-Q
22 05-13-2020 03-31-2020 10-Q
23 03-23-2020 12-31-2019 10-K
24 11-13-2019 09-30-2019 10-Q
25 08-13-2019 06-30-2019 10-Q
26 05-13-2019 03-31-2019 10-Q
27 03-19-2019 12-31-2018 10-K
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

Core News & Articles
12 Health Care Stocks Moving In Monday's A...
08/18/2025 21:06:13

hc-wainwright--co-reiterates-buy-on-diamedica-therapeutics-maintains-12-price-target
HC Wainwright & Co. Reiterates Buy on DiaM...
08/15/2025 11:11:34

HC Wainwright & Co. analyst Matthew Caufield reiterates DiaMedica Therapeutics (NASDAQ:DMAC) with a Buy and maintains $1...

diamedica-therapeutics-enters-sales-agreement-with-td-securities-may-sell-common-shares-up-to-100m
DiaMedica Therapeutics Enters Sales Agreem...
08/12/2025 21:37:38

-SEC Filing

diamedica-therapeutics-q2-eps-018-beats-019-estimate
DiaMedica Therapeutics Q2 EPS $(0.18) Beat...
08/12/2025 20:15:57

DiaMedica Therapeutics (NASDAQ:DMAC) reported quarterly losses of $(0.18) per share which beat the analyst consensus estimate o...

Core News & Articles
Earnings Scheduled For August 12, 2025
08/12/2025 08:32:28

exploring-diamedica-therapeuticss-earnings-expectations
Exploring DiaMedica Therapeutics's Earning...
08/11/2025 19:02:56

craig-hallum-maintains-buy-on-diamedica-therapeutics-raises-price-target-to-11
Craig-Hallum Maintains Buy on DiaMedica Th...
07/18/2025 15:57:35

Craig-Hallum analyst Chase Knickerbocker maintains DiaMedica Therapeutics (NASDAQ:DMAC) with a Buy and raises the price targ...

lake-street-maintains-buy-on-diamedica-therapeutics-raises-price-target-to-14
Lake Street Maintains Buy on DiaMedica The...
07/18/2025 15:48:28

Lake Street analyst Thomas Flaten maintains DiaMedica Therapeutics (NASDAQ:DMAC) with a Buy and raises the price target from...

hc-wainwright--co-maintains-buy-on-diamedica-therapeutics-raises-price-target-to-12
HC Wainwright & Co. Maintains Buy on DiaMe...
07/18/2025 10:51:16

HC Wainwright & Co. analyst Matthew Caufield maintains DiaMedica Therapeutics (NASDAQ:DMAC) with a Buy and raises the pr...

diamedica-therapeutics-announces-interim-results-from-part-1a-of-phase-2-study-of-dm199-for-treatment-of-preeclampsia
DiaMedica Therapeutics Announces Interim R...
07/17/2025 12:20:31

Conference Call Today July 17, 2025 at 4:30 PM Eastern Time / 3:30 PM Central TimeDM199 Demonstrated Highly Statistically Signi...

hc-wainwright--co-reiterates-buy-on-diamedica-therapeutics-maintains-10-price-target
HC Wainwright & Co. Reiterates Buy on DiaM...
05/29/2025 11:34:43

HC Wainwright & Co. analyst Matthew Caufield reiterates DiaMedica Therapeutics (NASDAQ:DMAC) with a Buy and maintains $1...

diamedica-therapeutics-announces-key-opinion-leader-webinar-on-dm199-for-the-treatment-of-preeclampsia-on-wednesday-may-28-2025-at-800-am-et
DiaMedica Therapeutics Announces Key Opini...
05/19/2025 13:06:05

Company to Host Preeclampsia Key Opinion Leader Event May 28, 2025 at 8 AM Eastern / 7 AM CentralDiaMedica Therapeutics Inc. (N...

diamedica-therapeutics-q1-eps-018-inline
DiaMedica Therapeutics Q1 EPS $(0.18), Inline
05/13/2025 20:30:52

DiaMedica Therapeutics (NASDAQ:DMAC) reported quarterly losses of $(0.18) per share which met the analyst consensus estimate. T...

Core News & Articles
Earnings Scheduled For May 13, 2025
05/13/2025 08:32:43

insights-ahead-diamedica-therapeuticss-quarterly-earnings
Insights Ahead: DiaMedica Therapeutics's Q...
05/12/2025 20:09:32

why-ericsson-shares-are-trading-higher-by-around-7-here-are-20-stocks-moving-premarket
Why Ericsson Shares Are Trading Higher By ...
04/15/2025 09:19:09

hc-wainwright--co-maintains-buy-on-diamedica-therapeutics-raises-price-target-to-10
HC Wainwright & Co. Maintains Buy on DiaMe...
03/19/2025 10:45:25

HC Wainwright & Co. analyst Matthew Caufield maintains DiaMedica Therapeutics (NASDAQ:DMAC) with a Buy and raises the pr...

diamedica-therapeutics-fy-2024-gaap-eps-060-misses-059-estimate
DiaMedica Therapeutics FY 2024 GAAP EPS $(...
03/17/2025 20:31:02

DiaMedica Therapeutics (NASDAQ:DMAC) reported quarterly losses of $(0.60) per share which missed the analyst consensus estimate...

earnings-scheduled-for-march-17-2025
Earnings Scheduled For March 17, 2025
03/17/2025 08:32:11

diamedica-therapeutics-highlights-publication-of-dm199s-mechanism-of-action-for-treatment-of-acute-ischemic-stroke-in-journal-of-stroke
DiaMedica Therapeutics Highlights Publicat...
02/20/2025 13:16:50

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION